{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T03:39:03Z","timestamp":1775792343360,"version":"3.50.1"},"reference-count":34,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T00:00:00Z","timestamp":1651104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>The use and interpretation of diagnostic cerebrospinal fluid (CSF) biomarkers for neurodegenerative disorders, such as Dementia with Lewy bodies (DLB), represent a clinical challenge. According to the literature, the composition of CSF in DLB patients varies. Some patients present with reduced levels of amyloid, others with full Alzheimer Disease CSF profile (both reduced amyloid and increased phospho-tau) and some with a normal profile. Some patients may present with abnormal levels of a-synuclein. Continuous efforts will be required to establish useful CSF biomarkers for the early diagnosis of DLB. Given the heterogeneity of methods and results between studies, further validation is fundamental before conclusions can be drawn.<\/jats:p>","DOI":"10.3390\/medicina58050612","type":"journal-article","created":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T22:20:06Z","timestamp":1651184406000},"page":"612","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Classical Cerebrospinal Fluid Biomarkers in Dementia with Lewy Bodies"],"prefix":"10.3390","volume":"58","author":[{"given":"Aikaterini","family":"Foska","sequence":"first","affiliation":[{"name":"2nd Department of Neurology, School of Medicine, National and Kapodistrian University of Athens, \u201cAttikon\u201d General University Hospital, 12462 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7582-7059","authenticated-orcid":false,"given":"Ioanna","family":"Tsantzali","sequence":"additional","affiliation":[{"name":"2nd Department of Neurology, School of Medicine, National and Kapodistrian University of Athens, \u201cAttikon\u201d General University Hospital, 12462 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleni","family":"Sideri","sequence":"additional","affiliation":[{"name":"2nd Department of Neurology, School of Medicine, National and Kapodistrian University of Athens, \u201cAttikon\u201d General University Hospital, 12462 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Ioanna","family":"Stefanou","sequence":"additional","affiliation":[{"name":"2nd Department of Neurology, School of Medicine, National and Kapodistrian University of Athens, \u201cAttikon\u201d General University Hospital, 12462 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleni","family":"Bakola","sequence":"additional","affiliation":[{"name":"2nd Department of Neurology, School of Medicine, National and Kapodistrian University of Athens, \u201cAttikon\u201d General University Hospital, 12462 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios K.","family":"Kitsos","sequence":"additional","affiliation":[{"name":"2nd Department of Neurology, School of Medicine, National and Kapodistrian University of Athens, \u201cAttikon\u201d General University Hospital, 12462 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Zompola","sequence":"additional","affiliation":[{"name":"2nd Department of Neurology, School of Medicine, National and Kapodistrian University of Athens, \u201cAttikon\u201d General University Hospital, 12462 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0509-5910","authenticated-orcid":false,"given":"Anastasios","family":"Bonakis","sequence":"additional","affiliation":[{"name":"2nd Department of Neurology, School of Medicine, National and Kapodistrian University of Athens, \u201cAttikon\u201d General University Hospital, 12462 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7443-5179","authenticated-orcid":false,"given":"Sotirios","family":"Giannopoulos","sequence":"additional","affiliation":[{"name":"2nd Department of Neurology, School of Medicine, National and Kapodistrian University of Athens, \u201cAttikon\u201d General University Hospital, 12462 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos I.","family":"Voumvourakis","sequence":"additional","affiliation":[{"name":"2nd Department of Neurology, School of Medicine, National and Kapodistrian University of Athens, \u201cAttikon\u201d General University Hospital, 12462 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Tsivgoulis","sequence":"additional","affiliation":[{"name":"2nd Department of Neurology, School of Medicine, National and Kapodistrian University of Athens, \u201cAttikon\u201d General University Hospital, 12462 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2481-3060","authenticated-orcid":false,"given":"George P.","family":"Paraskevas","sequence":"additional","affiliation":[{"name":"2nd Department of Neurology, School of Medicine, National and Kapodistrian University of Athens, \u201cAttikon\u201d General University Hospital, 12462 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,4,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S1474-4422(11)70213-7","article-title":"Pathological roles of \u03b1-synuclein in neurological disorders","volume":"10","author":"Vekrellis","year":"2011","journal-title":"Lancet Neurol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/s41593-019-0423-2","article-title":"Lewy pathology in Parkinson\u2019s disease consists of crowded organelles and lipid membranes","volume":"22","author":"Shahmoradian","year":"2019","journal-title":"Nat. Neurosci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"104876","DOI":"10.1016\/j.nbd.2020.104876","article-title":"Do Lewy bodies contain alpha-synuclein fibrils? and Does it matter? A brief history and critical analysis of recent reports","volume":"141","author":"Hilal","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer\u2019s disease: The IWG-2 criteria","volume":"13","author":"Dubois","year":"2014","journal-title":"Lancet Neurol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13195-014-0072-3","article-title":"Biomarkers in biological fluids for dementia with Lewy bodies","volume":"6","author":"Schade","year":"2014","journal-title":"Alzheimers Res. Ther."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.3233\/JAD-150731","article-title":"Diagnostic Value of Cerebrospinal Fluid Biomarkers (Phospho-Tau181, total-Tau, A\u03b242, and A\u03b240) in Prodromal Stage of Alzheimer\u2019s Disease and Dementia with Lewy Bodies","volume":"51","author":"Bousiges","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"ref_9","first-page":"174","article-title":"Diagnostic value of Alzheimer\u2019s biomarkers in cerebrospinal fluid in dementia with Lewy body","volume":"16","author":"Bousiges","year":"2018","journal-title":"Geriatr. Psychol. Neuropsychiatr. Vieil."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3233\/JAD-160322","article-title":"Cerebrospinal Fluid Alzheimer\u2019s Disease Biomarkers Across the Spectrum of Lewy Body Diseases: Results from a Large Multicenter Cohort","volume":"54","author":"Aarsland","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13195-019-0537-5","article-title":"Amyloid-\u03b2 peptides in cerebrospinal fluid of patients with dementia with Lewy bodies","volume":"11","author":"Scheltens","year":"2019","journal-title":"Alzheimers Res. Ther."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/mds.26668","article-title":"European DLB Consortium. Alzheimer\u2019s disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia","volume":"31","author":"Abdelnour","year":"2016","journal-title":"Mov. Disord."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000500567","article-title":"In vivo Prevalence of Alzheimer Biomarkers in Dementia with Lewy Bodies","volume":"47","author":"Paraskevas","year":"2019","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1212\/WNL.0b013e31823ed0f0","article-title":"Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort","volume":"78","author":"Schoonenboom","year":"2012","journal-title":"Neurology"},{"key":"ref_15","first-page":"1218","article-title":"Cerebrospinal Fluid Markers in Dementia With Lewy Bodies Compared With Alzheimer Disease","volume":"60","author":"Gonzalo","year":"2003","journal-title":"Arch. Neurol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Jellinger, K.A., and Korczyn, A.D. (2018). Are dementia with Lewy bodies and Parkinson\u2019s disease dementia the same disease?. BMC Med., 16.","DOI":"10.1186\/s12916-018-1016-8"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1093\/brain\/awy146","article-title":"Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated","volume":"141","author":"Robinson","year":"2018","journal-title":"Brain"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1159\/000327360","article-title":"Prevalence and pathology of dementia with Lewy bodies in the oldest old: A comparison with other dementing disorders. Dement","volume":"31","author":"Jellinger","year":"2011","journal-title":"Geriatr. Cogn. Disord."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13195-018-0356-0","article-title":"Improving the identification of dementia with Lewy bodies in the context of an Alzheimer\u2019s-type dementia","volume":"10","author":"Thomas","year":"2018","journal-title":"Alzheimers Res. Ther."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/ane.13028","article-title":"Lewy body pathology in Alzheimer\u2019s disease: A clinicopathological prospective study","volume":"139","author":"Savica","year":"2019","journal-title":"Acta Neurol. Scand."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000086472","article-title":"The Alzheimer variant of lewy body disease: A pathologically confirmed case-control study","volume":"20","author":"Perneczky","year":"2005","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.3233\/JAD-170274","article-title":"Accuracy of Clinical Diagnosis of Dementia with Lewy Bodies versus Neuropathology","volume":"59","author":"Skogseth","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"116886","DOI":"10.1016\/j.jns.2020.116886","article-title":"Novel fluid biomarkers to differentiate frontotemporal dementia and dementia with Lewy bodies from Alzheimer\u2019s disease: A systematic review","volume":"415","author":"Chaudhry","year":"2020","journal-title":"J. Neurol. Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S1474-4422(11)70014-X","article-title":"\u03b1-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: A cohort study","volume":"10","author":"Mollenhauer","year":"2011","journal-title":"Lancet Neurol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Kapaki, E., Paraskevas, P.G., Emmanouilidou, E., and Vekrellis, K. (2013). The diagnostic value of CSF \u03b1-synuclein in the differential diagnosis of dementia with Lewy bodies vs. normal subjects and patients with Alzheimer\u2019s disease. PLoS ONE., 8.","DOI":"10.1371\/journal.pone.0081654"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/mds.26578","article-title":"Longitudinal measurements of cerebrospinal fluid biomarkers in Parkinson\u2019s disease","volume":"31","author":"Hall","year":"2016","journal-title":"Mov. Disord."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1007\/s00415-018-8992-7","article-title":"Neuropsychiatric symptoms and \u03b1-Synuclein profile of patients with Parkinson\u2019s disease dementia, dementia with Lewy bodies and Alzheimer\u2019s disease","volume":"265","author":"Bougea","year":"2018","journal-title":"J. Neurol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Constantinides, V.C., Majbour, N.K., Paraskevas, G.P., Abdi, I., Safieh-Garabedian, B., Stefanis, L., El-Agnaf, O.M., and Kapaki, E. (2021). Cerebrospinal Fluid \u03b1-Synuclein Species in Cognitive and Movements Disorders. Brain Sci., 11.","DOI":"10.3390\/brainsci11010119"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e930","DOI":"10.1212\/WNL.0000000000012438","article-title":"Diagnostic Value of the CSF \u03b1-Synuclein Real-Time Quaking-Induced Conversion Assay at the Prodromal MCI Stage of Dementia with Lewy Bodies","volume":"97","author":"Rossi","year":"2021","journal-title":"Neurology"},{"key":"ref_30","first-page":"132","article-title":"Assessment of cerebrospinal fluid \u03b1-synuclein as a potential biomarker in Parkinson\u2019s disease and synucleinopathies","volume":"7","author":"Chalatsa","year":"2020","journal-title":"Neuroimmunol. Neuroinflamm."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/mds.28941","article-title":"Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as Biomarkers","volume":"37","author":"Barba","year":"2022","journal-title":"Mov. Disord."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/mds.28370","article-title":"Plasma Phospho-Tau Identifies Alzheimer\u2019s Co-Pathology in Patients with Lewy Body Disease","volume":"36","author":"Hall","year":"2021","journal-title":"Mov. Disord."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"805135","DOI":"10.3389\/fneur.2021.805135","article-title":"Fluid and Tissue Biomarkers of Lewy Body Dementia: Report of an LBDA Symposium","volume":"12","author":"Scott","year":"2022","journal-title":"Front. Neurol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Ayton, S., Hall, S., Janelidze, S., Kalinowski, P., Palmqvist, S., Belaidi, A.A., Roberts, B., Roberts, A., Stomrud, E., and Bush, A.I. (2022). The Neuroinflammatory Acute Phase Response in Parkinsonian-Related Disorders. Mov. Disord, Online ahead of print.","DOI":"10.1002\/mds.28958"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/58\/5\/612\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:02:36Z","timestamp":1760137356000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/58\/5\/612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,28]]},"references-count":34,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,5]]}},"alternative-id":["medicina58050612"],"URL":"https:\/\/doi.org\/10.3390\/medicina58050612","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,28]]}}}